Pliant Therapeutics Inc (PLRX)
11.92
+0.04
(+0.34%)
USD |
NASDAQ |
Apr 26, 12:14
Pliant Therapeutics Cash from Investing (Quarterly): 31.92M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 31.92M |
| September 30, 2023 | 38.25M |
| June 30, 2023 | -22.98M |
| March 31, 2023 | -174.21M |
| December 31, 2022 | 20.02M |
| September 30, 2022 | -178.25M |
| June 30, 2022 | 6.495M |
| March 31, 2022 | 1.531M |
| December 31, 2021 | 25.78M |
| September 30, 2021 | 32.10M |
| Date | Value |
|---|---|
| June 30, 2021 | 3.584M |
| March 31, 2021 | 12.23M |
| December 31, 2020 | 11.91M |
| September 30, 2020 | -105.08M |
| June 30, 2020 | -106.32M |
| March 31, 2020 | -11.37M |
| December 31, 2019 | -9.181M |
| September 30, 2019 | 13.75M |
| June 30, 2019 | 4.92M |
| March 31, 2019 | -27.42M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-178.25M
Minimum
Sep 2022
38.25M
Maximum
Sep 2023
-21.31M
Average
4.92M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| Masimo Corp | -25.30M |
| Liquidia Corp | -0.206M |
| Vor Biopharma Inc | 10.34M |
| CEL-SCI Corp | -0.0649M |
| AIM ImmunoTech Inc | -0.214M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -25.10M |
| Cash from Financing (Quarterly) | 0.219M |
| Free Cash Flow | -117.28M |
| Free Cash Flow Per Share (Quarterly) | -0.42 |
| Free Cash Flow Yield | -16.76% |